-
Something wrong with this record ?
The preventive and therapeutic effects of molecular hydrogen in ocular diseases and injuries where oxidative stress is involved
C. Cejka, S. Kubinova, J. Cejkova,
Language English Country England, Great Britain
Document type Journal Article, Review
- MeSH
- Humans MeSH
- Eye Diseases drug therapy pathology MeSH
- Oxidative Stress drug effects MeSH
- Hydrogen pharmacology therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Oxidative stress initiates, accompanies and contributes to the development of several human diseases and injuries, including ocular diseases. Reactive oxygen species (ROS) can generate oxidative stress via excessive ROS production and/or decreased physiologically occurring antioxidants. To replace these weakened antioxidants, substances with effective antioxidant properties are needed in order to suppress oxidative stress and enable healing. Molecular hydrogen (H2) is very suitable for this purpose due to its unique properties. H2 is the only antioxidant that crosses the blood-brain and blood-ocular barriers. It quickly penetrates through tissue due to its small molecular size and effectively removes ROS, mainly hydroxyl radicals and peroxynitrite. Apart from its antioxidant effects, H2 also displays anti-inflammatory, antiapoptotic, cytoprotective and mitohormetic properties. A significant advantage of H2 is its nontoxicity, even when applied at high concentrations. In this review, we present the results of studies utilising H2 in the treatment of ocular diseases involving oxidative stress. These results, obtained in experimental animals as well as in human clinical studies, show that the suppression of oxidative stress by H2 treatment leads to the prevention or improvement of ocular diseases. In severe degenerative diseases, H2 slows disease progression.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034769
- 003
- CZ-PrNML
- 005
- 20191011113618.0
- 007
- ta
- 008
- 191007s2019 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/10715762.2019.1582770 $2 doi
- 035 __
- $a (PubMed)30773939
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Cejka, Cestmir $u a Institute of Experimental Medicine , Czech Academy of Sciences , Prague , Czech Republic.
- 245 14
- $a The preventive and therapeutic effects of molecular hydrogen in ocular diseases and injuries where oxidative stress is involved / $c C. Cejka, S. Kubinova, J. Cejkova,
- 520 9_
- $a Oxidative stress initiates, accompanies and contributes to the development of several human diseases and injuries, including ocular diseases. Reactive oxygen species (ROS) can generate oxidative stress via excessive ROS production and/or decreased physiologically occurring antioxidants. To replace these weakened antioxidants, substances with effective antioxidant properties are needed in order to suppress oxidative stress and enable healing. Molecular hydrogen (H2) is very suitable for this purpose due to its unique properties. H2 is the only antioxidant that crosses the blood-brain and blood-ocular barriers. It quickly penetrates through tissue due to its small molecular size and effectively removes ROS, mainly hydroxyl radicals and peroxynitrite. Apart from its antioxidant effects, H2 also displays anti-inflammatory, antiapoptotic, cytoprotective and mitohormetic properties. A significant advantage of H2 is its nontoxicity, even when applied at high concentrations. In this review, we present the results of studies utilising H2 in the treatment of ocular diseases involving oxidative stress. These results, obtained in experimental animals as well as in human clinical studies, show that the suppression of oxidative stress by H2 treatment leads to the prevention or improvement of ocular diseases. In severe degenerative diseases, H2 slows disease progression.
- 650 _2
- $a oční nemoci $x farmakoterapie $x patologie $7 D005128
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a vodík $x farmakologie $x terapeutické užití $7 D006859
- 650 _2
- $a oxidační stres $x účinky léků $7 D018384
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kubinova, Sarka $u a Institute of Experimental Medicine , Czech Academy of Sciences , Prague , Czech Republic.
- 700 1_
- $a Cejkova, Jitka $u a Institute of Experimental Medicine , Czech Academy of Sciences , Prague , Czech Republic.
- 773 0_
- $w MED00007947 $t Free radical research $x 1029-2470 $g Roč. 53, č. 3 (2019), s. 237-247
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30773939 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191011114038 $b ABA008
- 999 __
- $a ok $b bmc $g 1451429 $s 1073319
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 53 $c 3 $d 237-247 $e 20190319 $i 1029-2470 $m Free radical research $n Free Radic Res $x MED00007947
- LZP __
- $a Pubmed-20191007